These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26355569)

  • 1. Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1.
    Bui JK; Mellors JW
    AIDS; 2015 Sep; 29(15):1911-5. PubMed ID: 26355569
    [No Abstract]   [Full Text] [Related]  

  • 2. Current understanding of HIV-1 and T-cell adaptive immunity: progress to date.
    Mohan T; Bhatnagar S; Gupta DL; Rao DN
    Microb Pathog; 2014 Aug; 73():60-9. PubMed ID: 24930593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intermittent therapy ought to strengthen the immune system].
    Volkert R
    Dtsch Med Wochenschr; 1999 Mar; 124(11):A8. PubMed ID: 10209528
    [No Abstract]   [Full Text] [Related]  

  • 4. T cells versus HIV-1: fighting exhaustion as well as escape.
    Robinson HL
    Nat Immunol; 2003 Jan; 4(1):12-3. PubMed ID: 12496971
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of HIV on naïve T-cell homeostasis.
    Grossman Z; Paul WE
    Nat Med; 2000 Sep; 6(9):976-7. PubMed ID: 10973313
    [No Abstract]   [Full Text] [Related]  

  • 6. [T cell immune response during HIV infection and immune escape].
    Wan YM; Chou C; Zhang XY; Xu JQ
    Bing Du Xue Bao; 2008 Jul; 24(4):326-33. PubMed ID: 18780640
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisation with gp160 in HIV-1 infection.
    Fiala C; Stewart GT
    Lancet; 1999 Sep; 354(9182):948; author reply 949. PubMed ID: 10489976
    [No Abstract]   [Full Text] [Related]  

  • 9. CDC revises AIDS definition.
    Am Nurse; 1993 Mar; 25(3):20. PubMed ID: 8383479
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV infection: where have all the T cells gone?
    Rowland-Jones S
    Lancet; 1999 Jul; 354(9172):5-7. PubMed ID: 10406356
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction: getting to the HAART of the matter: immune responses against the virus.
    Moss RB
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S133-4. PubMed ID: 9672229
    [No Abstract]   [Full Text] [Related]  

  • 13. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
    Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
    J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short Communication: HIV-1 Infection Suppresses Circulating Viral Restriction microRNAs.
    Zhou Y; Sun L; Wang X; Liang H; Ye L; Zhou L; Liang BY; Li JL; Liu MQ; Peng JS; Zhou DJ; Gui XE; Ho WZ
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):386-9. PubMed ID: 26607272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption.
    González-Serna A; Abad-Fernández M; Soriano-Sarabia N; Leal M; Vallejo A
    J Clin Virol; 2013 Dec; 58(4):703-9. PubMed ID: 24210957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of HIV-1 infection by soluble factors of the immune response.
    DeVico AL; Gallo RC
    Nat Rev Microbiol; 2004 May; 2(5):401-13. PubMed ID: 15100693
    [No Abstract]   [Full Text] [Related]  

  • 17. Limited efficiency of endogenous interleukin-7 levels in T cell reconstitution during HIV-1 infection: will exogenous interleukin-7 therapy work?
    Rethi B; Vivar N; Sammicheli S; Chiodi F
    AIDS; 2009 Apr; 23(7):745-55. PubMed ID: 19318908
    [No Abstract]   [Full Text] [Related]  

  • 18. Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions.
    Sadat-Sowti B; Parrot A; Quint L; Mayaud C; Debre P; Autran B
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):972-80. PubMed ID: 7511468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T cell immunity in HIV-1 infection.
    Munier CM; Kelleher AD; Kent SJ; De Rose R
    Curr Opin Virol; 2013 Aug; 3(4):438-46. PubMed ID: 23747036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shock and kill with caution.
    Gallo RC
    Science; 2016 Oct; 354(6309):177-178. PubMed ID: 27738158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.